Figure 4
From: Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
D2-40 immunoreactivity in ovarian serous carcinoma and papillary renal cell carcinoma. (a) Ovarian serous carcinoma, showing membranous immunoreactivity similar to that seen in epithelioid mesothelioma. (b) Papillary renal cell carcinoma, exhibiting diffuse but weak D2-40 immunostaining in a cytoplasmic pattern.
